This brand name is authorized in Brazil, France, United Kingdom
The drug OCUFEN contains one active pharmaceutical ingredient (API):
1
Flurbiprofen
UNII Z5B97MU9K4 - FLURBIPROFEN SODIUM
|
Flurbiprofen is a propionic acid derivative NSAID which acts through inhibition of prostaglandin synthesis. In humans flurbiprofen has potent analgesic, antipyretic and anti-inflammatory properties. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
OCUFEN Eye drops, solution | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
S01BC04 | Flurbiprofen | S Sensory organs → S01 Ophthalmologicals → S01B Antiinflammatory agents → S01BC Antiinflammatory agents, non-steroids |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 501004101170315 |
Country: FR | Base de données publique des médicaments | Identifier(s): 66565705 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 39784 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.